Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas
Author(s) -
Nikolai Klebanov,
William M. Lin,
Mykyta Artomov,
Michael F. Shaughnessy,
Ching-Ni Jenny Njauw,
Romi Bloom,
Agda Karina Eterovic,
Ken Chen,
Tae-Beom Kim,
Sandy S Tsao,
Hensin Tsao
Publication year - 2019
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2018.4231
Subject(s) - gnaq , germline mutation , medicine , angioma , melanoma , germline , pathology , mutation , genetics , dermatology , cancer research , gene , biology , vascular disease
Shared gene variants in benign-malignant process pairs, such as BRAF mutations common to benign nevi and melanoma, are associated with differing phenotypic manifestations. Study of gene mechanisms underlying cherry angioma may uncover previously unknown disease relationships.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom